The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II StudyWenqun Xing, Quanli Gao, Lingdi Zhao et al.|Frontiers in Immunology|2021Cited by 73
T Cells Expanded from PD-1+ Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating LymphocytesTiepeng Li, Quanli Gao, Lingdi Zhao et al.|Cancer Research|2021Cited by 40
Chemotherapy Reverses Anti-PD-1 Resistance in One Patient With Advanced Non-small Lung Cell CancerLingdi Zhao, Quanli Gao, Baozhen Ma et al.|Frontiers in Oncology|2020Cited by 32
High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center StudyLingdi Zhao, Quanli Gao, Tiepeng Li et al.|Frontiers in Immunology|2022Cited by 15
The sequence of chemotherapy and anti-PD-1 antibody influence the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell cancer: A phase II study.Lingdi Zhao, Quanli Gao, Wenqun Xing et al.|Journal of Clinical Oncology|2021Cited by 15